Albion Financial Group’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50 | Hold |
8
| – | – | ﹤0.01% | 579 |
|
|
2025
Q1 | $46 | Hold |
8
| – | – | ﹤0.01% | 600 |
|
|
2024
Q4 | $41 | Hold |
8
| – | – | ﹤0.01% | 676 |
|
|
2024
Q3 | $54 | Hold |
8
| – | – | ﹤0.01% | 501 |
|
|
2024
Q2 | $77 | Hold |
8
| – | – | ﹤0.01% | 501 |
|
|
2024
Q1 | $108 | Sell |
8
-1
| -11% | -$14 | ﹤0.01% | 489 |
|
|
2023
Q4 | $118 | Hold |
9
| – | – | ﹤0.01% | 465 |
|
|
2023
Q3 | $207 | Hold |
9
| – | – | ﹤0.01% | 460 |
|
|
2023
Q2 | $272 | Hold |
9
| – | – | ﹤0.01% | 450 |
|
|
2023
Q1 | $202 | Hold |
9
| – | – | ﹤0.01% | 431 |
|
|
2022
Q4 | $168 | Hold |
9
| – | – | ﹤0.01% | 470 |
|
|
2022
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 583 |
|
|
2022
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 639 |
|
|
2022
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 680 |
|
|
2021
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 703 |
|
|
2021
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 555 |
|
|
2021
Q2 | $0 | Buy |
+9
| New | – | ﹤0.01% | 536 |
|
|
2020
Q4 | $0 | Buy |
+9
| New | – | ﹤0.01% | 507 |
|